Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Comparison of the Ranger™ Paclitaxel-Coated PTA Balloon Catheter and Uncoated PTA Balloons in Femoropopliteal Arteries (RANGER-SFA)

This study is currently recruiting participants. (see Contacts and Locations)
Verified December 2014 by Hemoteq AG
Sponsor:
Collaborators:
Ceres GmbH evaluation & research
CoreLab Bad Krozingen GmbH
Information provided by (Responsible Party):
Hemoteq AG
ClinicalTrials.gov Identifier:
NCT02013193
First received: December 11, 2013
Last updated: December 16, 2014
Last verified: December 2014
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: April 2018
  Estimated Primary Completion Date: October 2015 (Final data collection date for primary outcome measure)